Valuation Bristol-Myers Squibb Company

Equities

Market Closed - Nyse Other stock markets 04:00:02 2026-01-15 pm EST			5-day change	1st Jan Change
56.62 ^USD	-0.70%		-0.18%	+4.97%

Jan. 13	Leerink Partners Adjusts Price Target on Bristol-Myers Squibb to $60 From $54, Maintains Outperform Rating	MT
Jan. 12	Bristol Myers Squibb Announces Positive Topline Results from Phase 3 SCOUT-HCM Trial Evaluating Camzyos in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	140,172	138,395	159,703	104,403	114,714	115,264	115,264	-
Change	-	-1.27%	15.4%	-34.63%	9.88%	0.48%	0%	-
Enterprise Value (EV) ¹	174,584	165,982	189,770	131,531	153,184	148,349	141,845	136,173
Change	-	-4.93%	14.33%	-30.69%	16.46%	-3.16%	-4.38%	-4%
P/E ratio	-15.5x	20x	24.4x	13.3x	-12.8x	13.8x	12.4x	12.3x
PBR	3.7x	3.73x	5.02x	3.48x	6.95x	5.69x	4.92x	4.31x
PEG	-	-0x	-4.48x	0.4x	0x	-0x	1.1x	45.57x
Capitalization / Revenue	3.3x	2.98x	3.46x	2.32x	2.38x	2.4x	2.61x	2.66x
EV / Revenue	4.11x	3.58x	4.11x	2.92x	3.17x	3.09x	3.22x	3.14x
EV / EBITDA	9.64x	8.1x	9.83x	7.52x	25.8x	9.14x	8.83x	8.65x
EV / EBIT	10x	8.37x	9.76x	7.84x	29.4x	9.52x	9.22x	9.02x
EV / FCF	13.1x	10.9x	15.9x	10.4x	11x	9.47x	10.3x	10.2x
FCF Yield	7.62%	9.18%	6.3%	9.62%	9.1%	10.6%	9.68%	9.77%
Dividend per Share ²	1.84	2.01	2.19	2.31	2.42	2.464	2.517	2.616
Rate of return	2.97%	3.22%	3.04%	4.5%	4.28%	4.35%	4.45%	4.62%
EPS ²	-3.99	3.12	2.95	3.86	-4.41	4.103	4.575	4.588
Distribution rate	-46.1%	64.4%	74.2%	59.8%	-54.9%	60%	55%	57%
Net sales ¹	42,518	46,385	46,159	45,006	48,300	47,970	44,105	43,348
EBITDA ¹	18,118	20,493	19,308	17,498	5,932	16,236	16,067	15,744
EBIT ¹	17,426	19,830	19,442	16,785	5,204	15,576	15,379	15,098
Net income ¹	-9,015	6,994	6,327	8,025	-8,948	8,193	8,936	8,919
Net Debt ¹	34,412	27,587	30,067	27,128	38,470	33,085	26,581	20,909
Reference price ²	62.03	62.35	71.95	51.31	56.56	56.62	56.62	56.62
Nbr of stocks (in thousands)	2,259,752	2,219,645	2,219,645	2,034,758	2,028,177	2,035,753	2,035,753	-
Announcement Date	2/4/21	2/4/22	2/2/23	2/2/24	2/6/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BRISTOL-MYERS SQUIBB COMPANY	13.9x	3.11x	9.19x	4.32%	116B
ELI LILLY AND COMPANY	46.89x	15.52x	34.45x	0.55%	961B
JOHNSON & JOHNSON	21.23x	5.89x	16.39x	2.36%	527B
ABBVIE INC.	75.19x	7.36x	17.64x	2.95%	392B
ROCHE HOLDING AG	20.01x	5x	12.44x	2.87%	368B
ASTRAZENECA PLC	29.15x	5.47x	16.22x	1.67%	299B
NOVARTIS AG	20.36x	5.38x	12.6x	2.81%	279B
MERCK & CO., INC.	14.22x	4.66x	10.01x	2.91%	276B
NOVO NORDISK A/S	16.39x	5.8x	11.99x	3.08%	262B
AMGEN INC.	25.73x	6.1x	10.45x	2.91%	177B
Average	28.31x	6.43x	15.14x	2.64%	365.67B
Weighted average by Cap.	33.33x	8.24x	19.26x	2.16%